Niles Chura, Chief Executive Officer

Mr. Chura possesses over two decades of leadership experience in the corporate, investment banking, and institutional investment arenas. He has held senior roles at several leading financial services firms in the U.S., including being the top-ranked Portfolio Manager at one of the largest private alternatives managers at the time ($40+B of AUM).

Mr. Chura was previously recruited to help co-launch a new capital markets strategy for a large healthcare direct lender. While there, he spearheaded an effort to acquire stressed Medicare Advantage programs. Subsequently, Mr. Chura co-founded a revenue-generating life sciences start-up that offers innovative financial and insurance solutions to help manufacturers, payers, providers, and patients manage the high cost and durability risk of potentially curative gene & cell therapies. He was awarded a patent for a related financial instrument that facilitates portability in compliance with U.S. healthcare regulations. He began his career as a field artillery officer in the U.S. Army serving overseas for three-and-a-half years.

Mr. Chura received an M.B.A. from Yale University and a B.A. in economics and government from The College of William & Mary in Virginia where he has been a guest lecturer for over 15 years. He has served as a member of the Boards of Directors for both public and private companies.